Skip to main content Skip to main content
Go to homepage

Pfizer-BioNTech seeks federal authorization for its vaccine for children 6 months to 4 years old

Michael Bigham, MD, the chief quality officer at Akron Children's, discusses Pfizer's recent request for vaccine approval and provides and update on the impact of COVID in local children.

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.